{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:31:04Z","timestamp":1792161064828,"version":"4.4.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00717","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:53:07Z","timestamp":1599007987000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":99,"title":["Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment"],"prefix":"10.3389","volume":"11","author":[{"given":"Katharine","family":"Boaden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneka","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2016.02.001","article-title":"Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012","volume":"26","author":"Bachmann","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-018-1244-7","article-title":"Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis","volume":"29","author":"Meister","year":"2020","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1408480","article-title":"Antidepressants\u2019 Black-Box Warning - 10 Years Later","volume":"371","author":"Friedman","year":"2014","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00294","article-title":"The FDA \u201cBlack Box\u201d Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits","volume":"10","author":"Fornaro","year":"2019","journal-title":"Front Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PloS Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis","volume":"388","author":"Cipriani","year":"2016","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16043-1","article-title":"Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data","volume":"363","author":"Whittington","year":"2004","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"Amstar 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"Br Med J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006997.pub2","article-title":"Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents","volume":"9","author":"Otasowie","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4088\/JCP.17r12064","article-title":"Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis","volume":"80","author":"Dobson","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004677.pub3","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)","author":"Williams","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008372.pub2","article-title":"Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents","author":"Hurwitz","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/01.ju.0000072341.34333.43","article-title":"Treatment of daytime urinary incontinence in children: a systematic review of randomized controlled trials","volume":"170","author":"Sureshkumar","year":"2003","journal-title":"J Urol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005170.pub2","article-title":"Pharmacotherapy for anxiety disorders in children and adolescents","volume":"3","author":"Ipser","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.2432","article-title":"Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis","volume":"74","author":"Locher","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.031088","article-title":"Efficacy of antidepressants in juvenile depression: meta-analysis","volume":"193","author":"Tsapakis","year":"2008","journal-title":"Br J Psychiatry"},{"key":"B18","first-page":"31","article-title":"Comparison of Moclobemide and Placebo in Young Adolescents with Major Depressive Disorder","volume":"8","author":"Avci","year":"1999","journal-title":"Ann Med Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(90)90050-q","article-title":"Adolescent Depression: A Placebo-Controlled Fluoxetine Treatment Study and Follow-Up. Prog","volume":"14","author":"Simeon","year":"1990","journal-title":"Neuro-Psychopharmacol. Biol Psychiat"},{"key":"B20","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/adc.57.9.714","article-title":"Controlled trial of imipramine in diurnal enuresis","volume":"57","author":"Meadow","year":"1982","journal-title":"Arch Dis Child"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2009.0115","article-title":"Sertraline treatment of children and adolescents with post-traumatic stress disorder: a double-blind, placebo-controlled trial","volume":"20","author":"Robb","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"CD002117","DOI":"10.1002\/14651858.CD002117.pub2","article-title":"Tricyclic and related drugs for nocturnal enuresis in children","author":"Caldwell","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0246-1072(18):81439-0","article-title":"Prescription d\u2019antid\u00e9presseurs chez les enfants et les adolescents [Prescription of antidepressants in children and adolescents]","volume":"15","author":"Benarous","year":"2018","journal-title":"EMC - Psychiatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1176\/pn.44.9.0002","article-title":"FDA approves antidepressant for use in adolescents","volume":"44","author":"Yan","year":"2009","journal-title":"Psychiatr News"},{"key":"B25","unstructured":"Depression in children and young people: identification and management (NICE guideline No. 134)2019"},{"key":"B26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41380-018-0116-3","article-title":"Treatment strategies for ADHD: an evidence-based guide to select optimal treatment","volume":"24","author":"Caye","year":"2019","journal-title":"Mol Psychiatry"},{"key":"B27","unstructured":"Post-traumatic stress disorder (NICE guideline No. 116)2018"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31129-2","article-title":"Autism spectrum disorder","volume":"392","author":"Lord","year":"2018","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000142196.41215.cc","article-title":"Practice parameter for the assessment and treatment of children and adolescents with enuresis","volume":"43","author":"Fritz","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"J Psychopharmacol"},{"key":"B31","unstructured":"Bedwetting in under 19s (NICE guideline No. 111)2010"},{"key":"B32","unstructured":"Obsessive-compulsive disorder and body dysmorphic disorder: treatment (NICE guideline No. 31)2005"},{"key":"B33","unstructured":"Neuroscience-based Nomenclature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2018.05.024","article-title":"What\u2019s in a Name? Moving to Neuroscience-Based Nomenclature in Pediatric Psychopharmacology","volume":"57","author":"Sultan","year":"2018","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1136\/ebmental-2018-300040","article-title":"Twenty years of progress in paediatric psychopharmacology: accomplishments and unmet needs","volume":"21","author":"Vitiello","year":"2018","journal-title":"Evid Based Ment Health"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/070674370705200903","article-title":"Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice","volume":"52","author":"Cipriani","year":"2007","journal-title":"Can J Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30307-8","article-title":"Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies","volume":"3","author":"Furukawa","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2018-300073","article-title":"Development and validation of a prediction model for the probability of responding to placebo in antidepressant trials: a pooled analysis of individual patient data","volume":"22","author":"Shinohara","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"B39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/eb-2017-102667","article-title":"Psychosocial interventions for self-harm, suicidal ideation and suicide attempt in children and young people: What? How? Who? and Where","volume":"20","author":"Cox","year":"2017","journal-title":"Evid Based Ment Health"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00018","article-title":"Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified","volume":"11","author":"Spielmans","year":"2020","journal-title":"Front Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300102","article-title":"How accurate are suicide risk prediction models? Asking the right questions for clinical practice","volume":"22","author":"Whiting","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"B42","unstructured":"Chapter V: Overviews of Reviews\n            PollockM\n            FernandesRM\n            BeckerLA\n            PieperD\n            HartlingL\n          \n            HigginsJPT\n            ThomasJ\n            ChandlerJ\n            CumpstonM\n            LiT\n            PageMJ\n            WelchVA\n          Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated March 2020). Cochrane2020"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028201","article-title":"What were the impacts of the Committee on Safety of Medicines warning and publication of the NICE guidelines on trends in child and adolescent antidepressant prescribing in primary care? A population based study","volume":"9","author":"Tiffin","year":"2019","journal-title":"BMJ Open"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","volume":"358","author":"Turner","year":"2008","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h4320","article-title":"Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence","volume":"351","author":"Le Noury","year":"2015","journal-title":"BMJ"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000140453.89323.57","article-title":"Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study","volume":"43","author":"Emslie","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2019.04.009","article-title":"Risks and Benefits of Attention-Deficit\/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases","volume":"86","author":"Chang","year":"2019","journal-title":"Biol Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300087","article-title":"Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: protocol for a network meta-analysis","volume":"22","author":"Tomlinson","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300121","article-title":"Withdrawal, dependence and adverse events of antidepressants: lessons from patients and data","volume":"22","author":"Tomlinson","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"B50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/ebmental-2019-300086","article-title":"Implementing a digital clinical decision support tool for side effects of antipsychotics: a focus group study","volume":"22","author":"Henshall","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300105","article-title":"One step closer to personalised prescribing of antidepressants: using real-world data together with patients and clinicians\u2019 preferences","volume":"22","author":"Kernot","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300118","article-title":"Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): rationale and protocol","volume":"23","author":"Tomlinson","year":"2020","journal-title":"Evid Based Ment Health"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ebmental-2019-300080","article-title":"Providing the most appropriate care to our individual patients","volume":"22","author":"Cipriani","year":"2019","journal-title":"Evid Based Ment Health"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00717\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:53:11Z","timestamp":1599007991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00717\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":53,"alternative-id":["10.3389\/fpsyt.2020.00717"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00717","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]},"article-number":"717"}}